/USPH

US Physical Therapy Inc

USPH

$78.72USD↑+1.30%+1.01 today

MARKET CAP

1.2B

P/E (TTM)

154.4x

FWD P/E

—

DAY RANGE

$78 – $80

52W RANGE

$58

$94

AI Summary

Stalk

StalkMedium

USPH is in a Stage 2 advancing phase within a confirmed uptrend, marked by higher highs and higher lows above rising EMAs. Price is extended above the 9/20 EMA regime and approaching the 200 DMA with extreme overbought readings, suggesting an imminent pullback. We will stalk for a corrective retracement into the 9/20 EMA and 50 DMA support zones before scaling exposure, consistent with a momentum‐oriented execution style.

↑Analysts forecast 22–25% upside to $88–$102 target prices
↑7.9% YoY revenue growth driven by outpatient rehabilitation demand
↓P/S ratio of 1.5x exceeds industry average of 1.4x

Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	2.26 M	155.51 M	+55.69 K	-6.1%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	129.87 K	8.92 M	+-4.27 K	-11.8%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	93.73 K	6.50 M	+-3.27 K	-10.4%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	91.35 K	6.27 M	+81.15 K	+720.6%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	71.00 K	4.88 M	+-5.96 K	-15.5%	0.01%
BA Balyasny Asset Management L.P. Q2 2026	BUY	37.36 K	2.57 M	+17.99 K	+76.7%	0.00%
MM Millennium Management LLC Q2 2026	BUY	36.42 K	2.50 M	+33.68 K	+1116.6%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	33.22 K	2.28 M	+-208.18 K	-87.4%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	19.84 K	1.36 M	+1.85 K	+1.1%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	11.78 K	881.61 K	+5.89 K	+91.7%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	2.92 K	200.68 K	+2.92 K	+0.0%	0.00%
MG Man Group Plc Q2 2026	SELL	0.00	0.00	+-46.30 K	-100.0%	0.00%